Prevention & care
Refractive errors: myopia, hyperopia, astigmatism, presbyopia, correction, and myopia-control evidence
On this page
A refractive error means light is not focused correctly on the retina, making vision blurry. It is an optical problem, not one identical disease or a complete explanation for every visual symptom.[1]
Four common labels describe different focusing problems
| Type | Main distinction |
|---|---|
| Myopia | Distant images are blurry; light focuses in front of the retina.[3] |
| Hyperopia | Light focuses behind the retina; near vision may be difficult.[4] |
| Astigmatism | Corneal or lens shape causes distorted or blurry vision at different distances.[5] |
| Presbyopia | Aging reduces the lens’s ability to focus at near distance.[6] |
Refraction describes how the eye bends light
The cornea and lens redirect light toward the retina. Eye length and the shape or flexibility of these optical structures affect the focal position. A refractive-error name describes this focusing relationship; it does not by itself describe retinal health, eye pressure or every reason that vision could be reduced.[2]
The categories can coexist
NEI explains that astigmatism often occurs alongside myopia or hyperopia, and that many people develop presbyopia in addition to another error. A person can therefore need different distance and near correction without one diagnosis replacing the other. The prescription and the health examination answer different questions.[2]
Myopia usually develops while the eye is growing
NEI describes onset commonly in childhood and progression into early adulthood. An eye that grows too long, or altered corneal or lens shape, focuses distant light in front of the retina. Family history matters, but an optical diagnosis cannot establish that one screen habit caused an individual case.[3]
High myopia is associated with other eye problems, including retinal detachment. Clear vision with glasses does not establish that those risks disappeared. Correcting focus and checking the retina are distinct purposes, even when the same appointment addresses both.[3]
Hyperopia is not simply the older-age reading-glasses problem
NEI describes hyperopia as often present from birth, although its symptoms may become apparent later. A shorter eye or optical-shape difference places the focal position behind the retina. Mild cases may produce few noticeable symptoms; an informal near-vision complaint cannot determine the underlying error.[4]
In children, substantial hyperopia can be associated with crossed eyes or amblyopia. The purpose of assessment may include visual development, not only whether the child complains about blur. Adult experience with reading glasses cannot supply a pediatric correction or observation plan.[4]
Astigmatism concerns shape, not a retina that is falling apart
The cornea or lens shape changes how light bends. Both nearby and distant objects can look distorted; symptoms can include eye strain or difficulty at night. Mild cases may go unnoticed. NEI states that its causes are not fully understood and does not describe a reliable prevention method.[5]
Presbyopia and hyperopia can produce similar complaints through different mechanisms
Presbyopia reflects a harder, less flexible aging lens. NEI distinguishes it from hyperopia even though both can make near tasks difficult. Moving a phone farther away can make print easier to see, but does not identify every cause of near-vision difficulty or restore the lens’s earlier flexibility.[6]
Larger print, suitable reading light and an appropriate near correction can improve function. Some people use reading glasses; others need a prescription addressing additional errors. A convenient pair of readers is not a substitute for investigating new or persistent visual problems.[6]
A focusing measurement and an eye-health examination have different purposes
NEI describes reading near and distant letters and checking for other problems during a comprehensive examination. Identifying an optical error does not exclude coexisting disease.[1]
An ordinary correction is not the same as a growth-control intervention
NEI’s January 2025 BLINK2 explanation distinguishes single-vision correction from specialized multifocal contacts intended also to slow eye growth. A child seeing clearly in their glasses is not, by that fact alone, evidence that myopia progression has stopped. Device design and intended outcome matter.[11]
Outdoor time concerns prevention and progression, not a universal optical cure
WHO’s February 2026 explanation includes daylight outdoor time, breaks during near work and appropriate prescribed optical interventions in childhood myopia strategies. It distinguishes these from presbyopia, hyperopia and astigmatism, for which it does not describe prevention. A promising behavior for one outcome should not be advertised as reversing every prescription.[7]
Refractive surgery changes optical shape
FDA describes benefits and possible harms of laser refractive procedures. A corneal operation can reduce dependence on correction, but reading glasses or further correction may still be needed. Its purpose differs from preventing retinal disease or reversing every aspect of lens aging.[8]
Possible harms include glare, halos, reduced low-contrast vision, under- or overcorrection and dry-eye problems. Good chart acuity and satisfactory night vision are different outcomes. FDA also explains that monovision deliberately gives the eyes different focusing roles, with potential depth-perception or low-light tradeoffs. A guarantee of “20/20” cannot capture the whole benefit–harm question.[8]
Correctable blur can still create a substantial access problem
WHO describes affordability, geography, service quality and unequal access to spectacles as barriers. Education, work and independence can be affected despite an available optical correction. A useful health resource should explain those practical needs rather than treating every uncorrected prescription as a personal lifestyle failure.[7]
New flashes or a curtain-like shadow need a different response
NEI advises immediate eye or emergency assessment for suspected retinal detachment, including sudden new floaters, flashes or a dark curtain. Do not assume that such a change only needs stronger glasses.[13]
Evidence & uncertainty
Clearer vision and slowing childhood eye growth are different goals. Selected myopia-control devices have evidence and a defined US authorization, while a June 2026 combination-treatment trial was still a research announcement. Neither establishes one best method for every child, all refractive errors or lifelong complication prevention.[9][10]
Selected-source overview · Independent review pendingPublished questions
Are myopia, hyperopia, astigmatism and presbyopia the same focusing disorder?
Selected-source overview · Independent review pending. Read the evidence context.
They describe different optical mechanisms and can coexist.[2]
Evidence behind this answer
- Types of Refractive Errors
agency condition or prevention explanation · 2025
Selected relevant original official page passages inspected · September 2025: optical mechanisms and overlapping errors
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Is presbyopia just another name for farsightedness?
Selected-source overview · Independent review pending. Read the evidence context.
Lens aging and hyperopia are different mechanisms.[6]
Evidence behind this answer
- Presbyopia
agency condition or prevention explanation · 2024
Selected relevant original official page passages inspected · December 2024: lens aging versus hyperopia, function and optical support
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Does correcting high myopia with glasses remove retinal-detachment risk?
Selected-source overview · Independent review pending. Read the evidence context.
Clearer focus does not establish removal of associated retinal risks.[3]
Evidence behind this answer
- Nearsightedness (Myopia)
agency condition or prevention explanation · 2024
Selected relevant original official page passages inspected · December 2024: childhood course, optical shape and high-myopia risks
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Why can childhood hyperopia matter even without a complaint about blur?
Selected-source overview · Independent review pending. Read the evidence context.
Visual development, crossed eyes and amblyopia can be relevant.[4]
Evidence behind this answer
- Farsightedness (Hyperopia)
agency condition or prevention explanation · 2024
Selected relevant original official page passages inspected · December 2024: focal position, symptoms and pediatric visual development
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Does clear distance vision in ordinary glasses show myopia progression has stopped?
Selected-source overview · Independent review pending. Read the evidence context.
Correction and slowing eye growth are different outcomes.[11]
Evidence behind this answer
- Contact lenses used to slow nearsightedness in youth have a lasting effect
agency research explanation · 2025
Selected relevant official page passages inspected · January 2025: distinction between ordinary correction and multifocal growth-control purpose
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Does the Stellest authorization cover every myopia-control lens and every age?
Selected-source overview · Independent review pending. Read the evidence context.
It names a particular device and treatment-start population.[9]
Evidence behind this answer
- FDA Authorizes Marketing of First Eyeglass Lenses to Slow Progression of Pediatric Myopia
regulatory device authorization · 2025
Selected relevant official page passages inspected · September 2025: Stellest, ages 6–12 at initiation, two-year study endpoints and De Novo pathway
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Did the June 2026 MTS2 announcement prove combined atropine and spectacle treatment works best?
Selected-source overview · Independent review pending. Read the evidence context.
It announces a comparison to be studied, not its results.[10]
Evidence behind this answer
- NEI launches clinical trial testing therapies that slow childhood myopia progression
agency trial announcement · 2026
Selected relevant official page passages inspected · June 2026 MTS2 launch: intended comparison, population, follow-up and support
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Does laser correction guarantee comfortable vision in every lighting condition?
Selected-source overview · Independent review pending. Read the evidence context.
Chart acuity, glare, dryness and low-contrast function can differ.[8]
Evidence behind this answer
- What are the risks and how can I find the right doctor for me?
agency condition or prevention explanation · Date not stated
Selected relevant original official page passages inspected · Selected LASIK risk, correction and monovision passages
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Stopping one contact-lens intervention was studied in older teens
The 2025 original BLINK2 report discusses two years of high-add multifocal lenses followed by a year of single-vision lenses. The reported increases after stopping were small and growth returned to age-expected rates using external benchmarks. This follow-up is not a newly randomized comparison of every stopping age, lens or childhood control method.[12]
A trial launch does not contain the trial’s results
NEI announced MTS2 in June 2026 to compare specialized spectacles, atropine drops and their combination in children aged 5 to under 12. It planned 24 months of treatment plus observation. NEI funding and manufacturer support for lenses were disclosed. The announcement cannot establish the combination’s outcome; full contemporary comparative appraisal remains incomplete.[10]
References
- Refractive Errors
Agency condition or prevention explanation
National Eye Institute · Content/publication date: 2025
Accessed: 2026-10-08 UTC · Selected relevant original official page passages inspected
Cited sections: December 2025: focusing definition and comprehensive examinationShared source with foundational eye page; combined attribution checked.
- Types of Refractive Errors
Agency condition or prevention explanation
National Eye Institute · Content/publication date: 2025
Accessed: 2026-10-08 UTC · Selected relevant original official page passages inspected
Cited sections: September 2025: optical mechanisms and overlapping errorsDefinition framework; not a comparative treatment review.
- Nearsightedness (Myopia)
Agency condition or prevention explanation
National Eye Institute · Content/publication date: 2024
Accessed: 2026-10-08 UTC · Selected relevant original official page passages inspected
Cited sections: December 2024: childhood course, optical shape and high-myopia risksNewer linked research distinguished from this page’s review date.
- Farsightedness (Hyperopia)
Agency condition or prevention explanation
National Eye Institute · Content/publication date: 2024
Accessed: 2026-10-08 UTC · Selected relevant original official page passages inspected
Cited sections: December 2024: focal position, symptoms and pediatric visual developmentNo child’s correction or individual risk assigned.
- Astigmatism
Agency condition or prevention explanation
National Eye Institute · Content/publication date: 2024
Accessed: 2026-10-08 UTC · Selected relevant original official page passages inspected
Cited sections: December 2024: corneal/lens shape, symptoms and cause uncertaintyMild or absent symptoms do not select an individual treatment.
- Presbyopia
Agency condition or prevention explanation
National Eye Institute · Content/publication date: 2024
Accessed: 2026-10-08 UTC · Selected relevant original official page passages inspected
Cited sections: December 2024: lens aging versus hyperopia, function and optical supportNewer presbyopia medicines are not comprehensively appraised here.
- Eye care, vision impairment and blindness: Refractive errors
Agency condition or prevention explanation
World Health Organization · Content/publication date: 2026
Accessed: 2026-10-08 UTC · Selected relevant original official page passages inspected
Cited sections: February 2026: myopia prevention/progression strategies and service-access barriersPublic-health explanation; no personal outdoor-time or treatment protocol.
- What are the risks and how can I find the right doctor for me?
Agency condition or prevention explanation
US Food and Drug Administration · Content/publication date: not stated
Accessed: 2026-10-08 UTC · Selected relevant original official page passages inspected
Cited sections: Selected LASIK risk, correction and monovision passagesUndated risk passages only; historical long-term-data wording not presented as a current evidence assessment.
- NEI launches clinical trial testing therapies that slow childhood myopia progression
Agency trial announcement
National Eye Institute · Content/publication date: 2026
Accessed: 2026-10-08 UTC · Selected relevant official page passages inspected
Cited sections: June 2026 MTS2 launch: intended comparison, population, follow-up and supportAnnouncement, not completed-trial outcomes or independently verified current recruitment status.
- Contact lenses used to slow nearsightedness in youth have a lasting effect
Agency research explanation
National Eye Institute · Content/publication date: 2025
Accessed: 2026-10-08 UTC · Selected relevant official page passages inspected
Cited sections: January 2025: distinction between ordinary correction and multifocal growth-control purposeAgency account of BLINK/BLINK2; not an independent replication.
- Axial Growth and Myopia Progression After Discontinuing Soft Multifocal Contact Lens Wear
Original trial follow up
Berntsen DA and BLINK Study Group; JAMA Ophthalmology · Content/publication date: 2025
Accessed: 2026-10-08 UTC · Original indexed abstract and selected original result passages inspected; no independent full-text appraisal
Cited sections: January 2025 original discussion: BLINK2 stopping phase, small changes and external age benchmarksSelected original indexed discussion; complete methods, funding and limitations not independently appraised.
- Retinal Detachment
Agency condition or prevention explanation
National Eye Institute · Content/publication date: 2025
Accessed: 2026-10-08 UTC · Selected relevant original official page passages inspected
Cited sections: November 2025: new floaters/flashes/curtain and immediate assessmentUrgent changes should not be assumed to need only new glasses.
Scope & review
- Population
- Optical-error literacy across ages; pediatric visual development and device-specific myopia-control settings distinguished
- Exposure or intervention
- Refraction, correction, growth-control purposes, lifestyle role, device authorization and surgery risks
- Comparison
- Source-specific symptom, care, screening or comparator settings
- Outcomes
- Visual clarity, function, eye growth, prescription change, adverse effects and access
- Timeframe
- Development and aging; dated 2024–2026 explanations and selected follow-up/authorization/announcement
- Jurisdiction
- Selected US/UK agency and professional guidance; jurisdiction and eligibility differences are labeled
Selected-source educational explanation. Official guidance, original study findings and editorial interpretation are distinguished. No exhaustive search, independent systematic synthesis or qualified medical review has been completed.
Sources checked on their individual access dates. Selected sources were checked; ongoing surveillance and qualified review have separate statuses on the coverage page.
Revision history
- 2026-10-08 UTC: Added a sourced explanation in a bounded ten-article batch; qualified review remains pending.
What this article still leaves open
- Independent eye-care review, complete contemporary myopia-control comparisons, prescription terminology, presbyopia medicines and long-term surgery outcomes remain incomplete.
- No prescription strength, child’s progression, outdoor-time target, device, eye drop or operation is selected for an individual.
Suggest a correction
Submit a content correction to the editorial queue, or download a local note. Leave out personal medical details. Submitted text is stored privately with a browser receipt session and is visible to this browser and the editor. Clearing cookies removes access to your submission history. This is not an account or a medical service.
Your submitted corrections for this article
Explore the topic map
Browse the health domains connected to this article. The map also identifies topics whose articles remain unwritten.